Ibandronate sodium - CAS 138926-19-9
Catalog number: 138926-19-9
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C9H23NO7P2.Na.H2O
Molecular Weight:
360.23
COA:
Inquire
Targets:
Others
Description:
Ibandronate (< 100 μM) inhibits growth of both prostate cancer cell lines (LNCaP and PC-3) in a dose dependent manner.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Synonyms:
BM-21.0955
MSDS:
Inquire
1.Effect of ibandronate on bending strength and toughness of rodent cortical bone: Possible implications for fracture prevention.
Savaridas T1, Wallace RJ2, Dawson S2, Simpson AH3. Bone Joint Res. 2015 Jun;4(6):99-104. doi: 10.1302/2046-3758.46.2000311.
OBJECTIVES: There remains conflicting evidence regarding cortical bone strength following bisphosphonate therapy. As part of a study to assess the effects of bisphosphonate treatment on the healing of rat tibial fractures, the mechanical properties and radiological density of the uninjured contralateral tibia was assessed.
2.Effect of ibandronate on bending strength and toughness of rodent cortical bone: Possible implications for fracture prevention.
Savaridas T1, Wallace RJ2, Dawson S2, Simpson AH3. Bone Joint Res. 2015 Jun;4(6):99-104. doi: 10.1302/2046-3758.46.2000311.
OBJECTIVES: There remains conflicting evidence regarding cortical bone strength following bisphosphonate therapy. As part of a study to assess the effects of bisphosphonate treatment on the healing of rat tibial fractures, the mechanical properties and radiological density of the uninjured contralateral tibia was assessed.
3.Monthly ibandronate versus weekly risedronate treatment for low bone mineral density in stable renal transplant patients.
Sánchez-Escuredo A1, Fuster D, Rubello D, Muxí A, Ramos A, Campos F, Marzola MC, Cook GJ, Tapias A, Torregrosa JV. Nucl Med Commun. 2015 Aug;36(8):815-8. doi: 10.1097/MNM.0000000000000316.
INTRODUCTION: Bisphosphonates may aid in treating and preventing bone loss promoted by chronic immunosuppressive treatment and secondary hyperparathyroidism in renal transplant (RT) patients. However, the effectiveness of bisphosphonates is compromised by poor patient compliance. The objective of the study was to compare the effects of once monthly ibandronate with those of weekly risedronate administration on bone mineral density (BMD) and renal function in RT patients.
4.Impurity profiling of ibandronate sodium by HPLC-CAD.
Wahl O1, Holzgrabe U2. J Pharm Biomed Anal. 2015 Oct 10;114:254-64. doi: 10.1016/j.jpba.2015.06.002. Epub 2015 Jun 6.
The modern bisphosphonate drug ibandronate sodium, a challenging candidate for impurity profiling, was analyzed using high performance liquid chromatography (HPLC) combined with corona charged aerosol detection (CAD). Separation was achieved on a mixed mode column combining hydrophobic C18 and strong anion exchange retention mechanisms using a mass spectrometer compatible volatile mobile phase consisting of trifluoroacetic acid and acetonitrile while gradient elution was applied. The method was validated following the ICH guideline Q2(R1) and found suitable for the assessment of ibandronate's related substances. The observed CAD-response for all identified impurities was linear (R(2)>0.995) over a small concentration range (0.05-0.25) and a quantification limit of at least 0.03% was found. Four batches of two different manufacturers were tested by means of the method. None of the batches contained a single impurity above 0.05%. The major impurities of all batches were the synthesis by-products N-desmethyl- and N-despentyl ibandronate as well as N,N-dimethyl pamidronate.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CAS 2179-37-5 Benzcyclane

Benzcyclane
(CAS: 2179-37-5)

Benzcyclane, also called as Bencyclane or Benzcyclan, is a platelet aggregation inhibitor and used as a vasodilator effective.

CAS 868224-64-0 SID 7969543

SID 7969543
(CAS: 868224-64-0)

SID 7969543 is a selective steroidogenic factor-1 (SF-1, NR5A1) inhibitor (IC50 = 0.76, >33 and >33 μM at SF-1, RORα and VP16, respectively). It also inhibits S...

CAS 84687-43-4 Astragaloside IV

Astragaloside IV
(CAS: 84687-43-4)

Astragaloside IV has cardiovascular protective effects. It can protect the vascular endothelial cells. Meanwhile, it also have antiinflammatory and anti-virus e...

CAS 72093-21-1 Mastoparan

Mastoparan
(CAS: 72093-21-1)

Mastoparan, a tetradecapeptide which is a component of wasp venom, activates Gi and Go and has been shown to cause an increase in the production of Arachidonic ...

Gly-Phe-Arg

Gly-Phe-Arg, a superpotent synthetic tripeptide, mimics the mud-crab pumping pheromone.

CAS 55395-07-8 IKarisoside A

IKarisoside A
(CAS: 55395-07-8)

IKarisoside A is a natural compound isolated from Epimedium koreanum, which has anti-inflammatory properties.

DPY-3050
(CAS: 30103-05-0)

DPY-3050 is a useful intermediate for chemical synthesis of a number of biologically active drugs.

U-75875
(CAS: 112190-24-6)

U-75875 is a protease inhibitor. It is also a peptidomimetic inhibitor and could inhibit HIV-1 gag-pol protein. It completely blocked HIV replication in human p...

CAS 123714-50-1 Acetyl-Calpastatin (184-210) (human)

Acetyl-Calpastatin (184-210) (human)
(CAS: 123714-50-1)

Acetyl-Calpastatin (184-210) (human) is a calpain I/II inhibitor and could increase secretion of amyoid β-protein (Aβ) 42, Aβ40 and Aβ42 ratio.

CAS 1439934-41-4 CTX-0294885

CTX-0294885
(CAS: 1439934-41-4)

CTX-0294885 is a novel broad-spectrum kinase inhibitor. CTx-0294885 exhibits inhibitory activity against a broad range of kinases in vitro. Use of a quantitativ...

CAS 116680-01-4 Mycophenolate mofetil hydrochloride

Mycophenolate mofetil hydrochloride
(CAS: 116680-01-4)

Mycophenolate mofetil is a non-competitive, selective and reversible inhibitor of inosine monophosphate dehydrogenase I/II with IC50 of 39 nM and 27 nM, respect...

CAS 3902-71-4 Trioxsalen

Trioxsalen
(CAS: 3902-71-4)

A derivative of psoralen, which intercalates into DNA and forms DNA single-strand adducts and interstrand crosslinks.

CAS 1258275-73-8 TMPA

TMPA
(CAS: 1258275-73-8)

TMPA is an antagonist of nuclear receptor Nur77 (Kd = 1.45 ± 0.35 μM) and LKB1 interaction.

CAS 297730-17-7 AVN-944

AVN-944
(CAS: 297730-17-7)

AVN-944 (VX-944) is an orally available, synthetic small molecule with potential antineoplastic activity. AVN944 inhibits inosine monosphosphate dehydrogenase (...

CAS 42794-76-3 Midodrine

Midodrine
(CAS: 42794-76-3)

Midodrine is an α1-receptor agonist and exerts its actions via activation of the alpha-adrenergic receptors of the arteriolar and venous vasculature.

CAS 71283-80-2 Fenoxaprop-p-ethyl

Fenoxaprop-p-ethyl
(CAS: 71283-80-2)

Fenoxaprop-P-ethyl is a post-emergent phenoxy herbicide for control of postemergence annual grasses in crop fields.

CAS 132623-44-0 CCMQ

CCMQ
(CAS: 132623-44-0)

CCMQ is an inhibitor of homoquinolinic acid binding to non-NMDA sensitive sites. It is combined with [3H]-homoquinolinic acid to characterize NR2B-containing NM...

EN460
(CAS: 496807-64-8)

EN460 is a small molecule inhibitor by EN460 binding to ERO1α to promote the loss of flavin adenine dinucleotide (FAD) from the holoenzyme(IC50=1.9 uM) .

GnRH-I

GnRH-I, a small 10 amino acid long peptide (decapeptide) from the hypothalamus, has previously been demonstrated and shown to be biologically active in the immu...

CAS 1797406-69-9 MZ 1

MZ 1
(CAS: 1797406-69-9)

MZ 1, a hybrid compound that drives the selective proteasomal degradation of bromodomain-containing protein 4 (BRD4), retains high affinity for BRD2, BRD3 and B...

Chemical Structure

CAS 138926-19-9 Ibandronate sodium

Quick Inquiry

Verification code

Featured Items